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ABSTRACT:
A
non-specific
exopeptidase,
aminopeptidase N (APN), is inhibited sequence
specifically by a synthetic host, cucurbit[7]uril (Q7),
which binds with high affinity and specificity to Nterminal phenylalanine (Phe) or 4-aminomethyl
phenylalanine (AMPhe) and prevents their
removal from the peptide. Liquid chromatography
experiments demonstrate that in the presence of
excess Q7, APN quantitatively converts the
pentapeptides
Thr-Gly-Ala-X-Met
into
the
dipeptides X-Met (X = Phe or AMPhe). The
resulting Q7-bound products are completely stable
to proteolytic digestion for at least 24 h. Structureactivity studies reveal a direct correlation between
the extent of protection of an N-terminal amino
acid and its affinity for Q7. Therefore, Q7 provides
predictable sequence specificity to an otherwise
non-specific protease and enables the production of
a single peptide product. Conversely, APN
uncovers a high-affinity epitope, which is then
bound by Q7, and thus this approach should also
facilitate the molecular recognition of peptides.

Methods for selective enzymatic digestion of
peptides and proteins are crucial to many
processes in molecular biology and biotechnology.
Proteases are used widely to process polypeptides
for sequencing1 and other applications in
proteomics2 and medicine.3 Endopeptidases, which
cleave the peptide backbone at nonterminal sites,
typically have well-defined sequence specificity.
Exopeptidases, which remove amino acids
sequentially from a terminus, can be specific for a
small set of amino acids or generally non-specific,
which allows them to digest a peptide completely
into amino acids.4,5 Developing methods that

change the substrate specificity of proteases would
broaden the scope of their applications. Here we
show that a synthetic receptor, cucurbit[7]uril (Q7),
can be used to impart specificity to an otherwise
non-specific exopeptidase, porcine aminopeptidase
N (APN), by binding to a specific residue and
inhibiting its removal from the peptide.
Q7 is a highly stable container molecule that
can associate noncovalently with a wide range of
cationic organic guests in aqueous media with
equilibrium association constant (Ka) values of up
to 1015 M-1.6-8 We and others have studied the
capacity of Q7 to bind to amino acids, peptides,
and proteins and found that Q7 prefers to bind Nterminal phenylalanine (Phe), tyrosine (Tyr), and
tryptophan (Trp) residues, by incorporating the
sidechain within the nonpolar Q7 cavity and
chelating the N-terminal ammonium group with
Q7 carbonyl oxygens.9-14 Nau and coworkers have
shown that Q7 can slow the activity of an
endopeptidase, trypsin, and an exopeptidase,
leucine aminopeptidase (LAP), by binding to their
respective substrates.15,16 In both cases, they
observed only partial and short-lived inhibition.
We hypothesized that this approach could be used
to crop a complete sample of peptide down to the
first Phe residue if the aminopeptidase could be
inhibited exclusively at this position.
LAP was not completely inhibited by Q7,15,16
and thus we wanted to test a different
aminopeptidase. APN was chosen for its lack of
specificity,4 its medicinal relevance,17 and its
commercial availability. The pentapeptide, ThrGly-Ala-Phe-Met (1), was chosen as the first
substrate for APN digestion because it contains five
different amino acid residues, including hydrophilic and hydrophobic sidechains, and it contains

complex, and electrospray ionization mass spectrometry (ESI-MS) confirmed the digestion product as

Figure 1. (left) Schematic illustration of the inhibition
of APN-mediated peptide digestion at a Phe residue
using Q7. (right) Chemical formula of Q7 and schematic of the molecular recognition of N-terminal Phe.

a non-terminal Phe residue, which becomes the Nterminal residue after APN removes the Thr, Gly,
and Ala residues (Figure 1). The entrance to the
catalytic site of APN is highly constricted, and
specific interactions are made with the sidechain of
the terminal residue.18 Q7 should protect an Nterminal Phe by encapsulating its sidechain and
interacting directly with the terminal ammonium
group (Figure 1). Peptide 1 and the predicted
product of digestion, Phe-Met (2), were
synthesized. These peptides and the others used in
this study have C-terminal amides because they
were synthesized on Rink amide resin.
Analytical HPLC was used to monitor the
digestion of 0.50 mM peptide 1 by 0.20 M APN in
the absence of Q7 and in the presence of a
substoichiometric
quantity
(0.25
mM),
a
stoichiometric quantity (0.50 mM), and a 2-fold
excess (1.0 mM) of Q7 (Figure 2). Samples were
analyzed at reaction times of 5 min, 3 h, and 24 h.
At the 5 min time point, we observed substantial
degradation of the starting material (retention time
21-22 min) in the absence of Q7 and at 0.25 mM Q7,
and substantially slower degradation with 0.50 mM
and 1.0 mM Q7.
At the 3 h time point (Figure 2b), all samples
showed complete disappearance of starting
material. Remarkably, only one peak (at ~6 min)
remained in the HPLC traces of the samples
containing 0.50 mM and 1.0 mM Q7. The broad
shape and retention time of these peaks correspond
exactly to those of a standard sample of the Q7•2

Figure 2. Analytical HPLC traces of the digestion of
0.5 mM Thr-Gly-Ala-Phe-Met (1) with 0.20 M APN
in the presence of 0, 0.5, 1.0, or 2.0 molar equivalents
of Q7 at 37 C in 10 mM ammonium phosphate, pH
7.2. Reaction times are (a) 5 min, (b) 3 h, and (c) 24 h.

the Q7•2 complex (see Supporting Information).
The conversion of pentapeptide 1 to the Q7•2
complex was quantified by comparing the area of
the product peak with that of a standard sample of
Q7•2. We observed quantitative conversion (101%
±1.1% and 98% ±1.3%) in the presence of 1.0 mM
Q7 and 0.50 mM Q7, respectively. With
substoichiometric Q7 (0 or 0.25 mM), however,
there was no substantial formation of the Q7•2
product. Instead, we observed a peak at ~4 min that
corresponds to the free Phe amino acid.
At the 24 h time point (Figure 2c), there was no
change in the HPLC trace of the sample containing
1.0 mM Q7. This result indicates that the Q7•2
complex is highly stable under these conditions. In
the sample containing 0.5 mM Q7, we observed a
37% reduction in the area of the Q7•2 peak.19
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Therefore, an excess of Q7 is needed to protect the
Q7•2 product over longer periods of time.
Table 1. Peptide Protection vs. the Binding Constant.

Peptide

Residual
Peptide (%)

Ka (M-1) c

Phe-Met (2)

93.9 (±1.1)a

Phe-Met (2)

100.4 (±1.4)b

Tyr-Met (3)

19.8 (±3.5)a

6.4 (±0.4) x 105

(±0.1)a

2.3 (±0.1) x 105

101.6 (±1.5)a

5.3 (±1.1) x 108

Trp-Met-Gly (4)
AMPhe-Met (5)

1.5

compares these values to their binding affinities for
Q7, as determined by isothermal titration
calorimetry (ITC). These data reveal a direct
correlation between binding affinity and extent of
protection by Q7, and they demonstrate that Q7

1.4 (±0.1) x 107

Fraction of 0.50 mM peptide that remains after 24
h in the presence of 1.0 mM Q7, 0.20 M APN. b Fraction of 0.10 Phe-Met that remains after 24 h in the
presence of 1.0 mM Q7, 0.040 M APN. All experiments were performed at 37 C in 10 mM ammonium
phosphate, pH 7.2, and values were determined by
integrated peak intensities in the HPLC traces of
samples after 24 h. c Mean values measured from at
least three ITC experiments at 27 C in 10 mM ammonium phosphate, pH 7.2. Standard deviations are given in parentheses.
a

It is interesting to consider how the increased
concentrations of Q7 impeded initial degradation
of the substrate at the 5 min time point. In the
samples containing 0.50 mM and 1.0 mM Q7,
appreciable quantities of the Q7•2 complex had not
yet formed, but enzymatic activity was clearly
retarded. Higher Q7:1 ratios were needed to form
and protect the Q7•2 product at 3 h and 24 h.
These results suggest that Q7 also has a small
inhibitory effect by binding to the enzyme but that
inhibition of proteolysis is primarily governed by
binding to the substrate, as observed for LAP.15
The highest affinity binding sites for Q7 on
natural peptides are at N-terminal Phe, Tyr, and
Trp residues (Ka ~105-107 M-1); other potential
binding sites have much weaker affinities.9 In order
to assess the extent to which Q7 can protect these
residues from APN digestion, we prepared a series
of peptides with different aromatic N-termini and
measured the extent of their protection by Q7 in
the presence of APN. Phe-Met (2), Tyr-Met (3), and
Trp-Met-Gly (4), each at 0.50 mM, were incubated
for 24 h with 1.0 mM Q7 and 0.20 M APN and
then analyzed by HPLC. Table 1 gives the residual
quantities of peptides that remain after 24 h and

Figure 3. Analytical HPLC traces of the reaction of 0.5
mM Thr-Gly-Ala-AMPhe-Met (6) with 0.20 M in the
presence of 0.83 mM Q7 at 37 C in 10 mM ammonium phosphate, pH 7.2.

inhibits APN degradation most effectively at a Phe
residue. Given the clear substrate-inhibition
mechanism, we should be able to increase the ratio
of Q7:2 in order to increase the extent of protection
by Q7. To test this hypothesis, we increased the
ratio of Q7:2 to 10:1 and, in fact, observed complete
retention of peptide 2 after 24 h (Table 1).
Considering the correlation between the extent
of peptide protection and its binding affinity to Q7,
we were interested in examining a stronger binding
site. N-terminal Phe is the preferred epitope in
native peptides, but we found recently that Q7 can
bind with nanomolar affinity to peptides containing
a 4-aminomethyl phenylalanine (AMPhe) residue
at the N-terminal position (Figure 3).20 Indeed, we
observed quantitative protection of AMPhe-Met (5)
(Ka = 5.3 x 108 M-1) from APN digestion in the
presence of two equivalents of Q7 (Table 1).
Given the strong protection of AMPhe-Met (5)
by Q7, we wanted to test the ability of Q7 to inhibit
the complete digestion of a peptide containing a
non-terminal AMPhe residue. Therefore, we
synthesized the pentapeptide Thr-Gly-Ala-AMPheMet (6) and followed its degradation by APN using
analytical HPLC (Figure 3). We observed
substantial retention of starting material until at
least 3 h, with complete disappearance of starting
material by 16 h. Up to 3h, three new peaks in the
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2-5 min range grew, but at 16 h only a single peak
remained (at ~4 min). This remaining peak
correlates exactly with a standard sample of the
Q7•5 complex and was confirmed to be the Q7•5
complex by ESI-MS (see Supporting Information).
In the absence of Q7, the peptide was digested
completely into amino acids.
These results demonstrate that Q7 can
completely inhibit the removal of Phe and AMPhe
residues from the N-terminal position of peptides
by APN. In doing so, a peptide containing an
internal Phe or AMPhe is cropped down to that
residue. Therefore, Q7 imparts predictable
sequence-specificity to an otherwise non-specific
exopeptidase and enables the production of a
single peptide product. This constitutes a novel
approach to peptide processing that is specific,
quantitative, and effective under mild conditions
(pH 7.2 buffer, 37 C). Proteolysis is inhibited only
when APN has reached a target residue.
Conversely, if APN is inhibited, then a rare highaffinity epitope (e.g., the N-terminal Phe) has been
uncovered, and the resulting peptide product is
bound by Q7. Therefore, this method may also
facilitate the recognition and labeling of peptides at
a single site.12,21-24 It remains to be seen whether the
method will work with longer polypeptides or
with other receptor/protease pairs. Work in this
area is ongoing and will be reported in due course.
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